Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 23, 2025, Quantum Genomics SA (ALQGC.PA) has a market cap of $5.226 million USD. According to our data, Quantum Genomics SA is ranked No.9036 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 23, 2025 | $5.23 M |
-0.00%
|
| Dec 31, 2024 | $5.23 M |
-31.98%
|
| Dec 29, 2023 | $7.68 M |
-10.17%
|
| Dec 30, 2022 | $8.55 M |
175.31%
|
| Dec 31, 2021 | $3.11 M |
-12.53%
|
| Dec 31, 2020 | $3.55 M |
44.97%
|
| Dec 31, 2019 | $2.45 M |
-36.70%
|
| Dec 31, 2018 | $3.87 M |
69.52%
|
| Dec 29, 2017 | $2.28 M |
-57.20%
|
| Dec 30, 2016 | $5.34 M |
-13.22%
|
| Dec 30, 2015 | $6.15 M |
53.96%
|
| Dec 31, 2014 | $3.99 M |
-6.86%
|
| Dec 31, 2013 | $4.29 M |
-43.33%
|
| Dec 28, 2012 | $7.57 M |
-60.00%
|
| Dec 30, 2011 | $18.91 M |
0.00%
|
| Dec 30, 2010 | $18.91 M |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
 AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
 Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
 Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
 GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
 Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
 Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
 Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
 Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
 Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
 Takeda Pharmaceutical
TAK
|
$40.87 B |
0.001 M
|
Japan
|
 AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
 Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
| Market Cap | = | ALQGC.PA Stock Price | * | ALQGC.PA Shares Outstanding |
| = | $0.08 | * | 69.62 M | |
| = | $5.23 M |